English
English
登录 ×
重置密码 ×

请通过电子邮件获取并输入验证码,然后输入新密码,然后单击重置密码按钮。您的密码必须至少为 7 个字符,并带有数字和字母。

注册 ×

登录

必须至少有7个字符,同时带有数字和字母

  我已阅读并同意RDD的条款和条件

用户条款协议

×

使用指南

Ensuring Permanent Traceability:

Maintain a lifelong record of raw data.

Accountability to oneself and fostering community confidence:
Uphold academic integrity and inspire trust within the academic community
RDD搜索

搜索结果 :

RDD 编号
论文/项目标题
Camrelizumab plus nab-paclitaxel in patients for previously treated advanced urothelial carcinoma: a multicentre, phase II study
作者列表
Haifeng Li
lihf@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Meiting Chen
chenmt@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Riqing Huang
huangrq@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Qixiang Rong
keetxiang@163.com
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Jing Hao
haojing@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Qiufan Zheng
zhengqf@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Yanhong Su
suyh1@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Ditian Shu
shudt@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Yue Zhang
zhangyue@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Wei Yang
15285130704@163.com
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Xuefen Lei
leixuefen@kmmu.edu.cn
Department of Medical Oncology,The Second Affiliated Hospital of Kunming Medical University
通讯作者
Yuchen Cai
caiych@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
CongXue
xuecong@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Xin An
anxin@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
Yanxia Shi
shiyx@sysucc.org.cn
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Ascentage Pharma Group Inc., Rockville, MD, USA
通讯作者
上传者
keetxiang@163.com
上传者的隶属关系
中山大学肿瘤防治中心
存储日期
2026/1/26 17:37:32